Cheap or Value Trap? Nike, PayPal and Novo Nordisk on P/E

Описание: Nike, PayPal, and Novo Nordisk are all down about 75% or more from their highs, and all three look cheap on price-to-earnings. So are they bargains or value traps? We check each one with real numbers, every step on screen and dated.

You will see:
what a P/E ratio really measures, and why you must ask which year of profit
why Nike is not cheap on next year's expected profit (about 17 times becomes about 27)
how a single accounting entry makes Novo Nordisk look cheaper than it is
EV/EBITDA, the cousin of P/E that sees the debt
why PayPal is cheap on every measure we tried, and the reason the market gives
three questions that tell a bargain from a value trap, for any stock

Chapters
0:00 Three cheap stocks
1:18 What P/E really says
2:14 Nike: which earnings?
4:02 Novo Nordisk: the one-off
5:52 The cousin: EV/EBITDA
6:59 PayPal: cheap with a reason
8:39 What the multiples say each is worth
10:18 Three questions: cheap or trap?
11:31 Recap

All prices are from October 13, 2026. Figures come from company filings, company guidance and market data. At ACCE Investments we run valuation models like these on more than 5,000 stocks and show each step on the stock pages: https://acceinvestments.com/yt

Next video: margin of safety. How cheap does a stock have to be before it is worth the risk?
Which stock should we put through the three questions? Tell us in the comments.

This video is for education only. It is not investment advice, and a multiple is only as good as the profit behind it.